We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMNM icon
276
Immunome
IMNM
$2.62B
$10.1M 0.05%
859,527
+541,441
+170% +$5.39M
COR icon
277
Cencora
COR
$62B
$10M 0.05%
32,117
+1,022
+3% +$301K
MRSH
278
Marsh
MRSH
$94.3B
$10M 0.05%
49,765
-2,047
-4% -$421K
IMCR icon
279
Immunocore
IMCR
$1.7B
$9.8M 0.05%
269,729
+134,950
+100% +$4.58M
BE icon
280
Bloom Energy
BE
$48.2B
$9.68M 0.05%
114,479
-411,333
-78% -$19.1M
HWM icon
281
Howmet Aerospace
HWM
$109B
$9.68M 0.05%
49,311
+884
+2% +$161K
KDP icon
282
Keurig Dr Pepper
KDP
$42.8B
$9.63M 0.05%
377,667
+127,389
+51% +$3.99M
VC icon
283
Visteon
VC
$2.85B
$9.59M 0.05%
+80,025
New +$9.42M
COIN icon
284
Coinbase
COIN
$42.2B
$9.3M 0.05%
27,550
-846
-3% -$287K
BCYC
285
Bicycle Therapeutics
BCYC
$269M
$9.07M 0.05%
1,172,387
PTCT icon
286
PTC Therapeutics
PTCT
$6.18B
$8.98M 0.05%
146,265
-2,330
-2% -$121K
VRSN icon
287
VeriSign
VRSN
$26.3B
$8.9M 0.05%
31,820
-205
-0.6% -$57.3K
MEDP icon
288
Medpace
MEDP
$16.3B
$8.85M 0.05%
17,221
-34,434
-67% -$15M
AMT icon
289
American Tower
AMT
$83.5B
$8.79M 0.05%
45,682
-591
-1% -$123K
VRSK icon
290
Verisk Analytics
VRSK
$27.7B
$8.63M 0.05%
34,323
-523
-2% -$144K
ZBRA icon
291
Zebra Technologies
ZBRA
$13.5B
$8.59M 0.05%
28,916
+2,819
+11% +$901K
SRRK icon
292
Scholar Rock
SRRK
$5.88B
$8.56M 0.04%
229,900
-109,433
-32% -$3.83M
ALAB icon
293
Astera Labs
ALAB
$42.8B
$8.56M 0.04%
43,700
+102
+0.2% +$16.8K
LEGN icon
294
Legend Biotech
LEGN
$3.65B
$8.54M 0.04%
261,815
DOV icon
295
Dover
DOV
$26.7B
$8.36M 0.04%
50,127
+2,740
+6% +$492K
BSY icon
296
Bentley Systems
BSY
$11.2B
$8.32M 0.04%
161,705
+11,491
+8% +$630K
CNTA
297
DELISTED
Centessa Pharmaceuticals
CNTA
$8.32M 0.04%
343,207
-4,392
-1% -$78.1K
ITT icon
298
ITT
ITT
$17.1B
$8.26M 0.04%
46,205
+24,270
+111% +$4.07M
CEG icon
299
Constellation Energy
CEG
$92.1B
$8.16M 0.04%
24,795
+175
+0.7% +$56.5K
WMB icon
300
Williams Companies
WMB
$85.8B
$8.03M 0.04%
126,808
-91
-0.1% -$5.34K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.